| Financial Year |
March 31 2023 |
| Monetary Funds |
403,217,790.92 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
27,534,722.69 |
| Accounts Receivable |
2,025,462,824.67 |
| Advances to Suppliers |
88,913,287.87 |
| Other Receivables |
74,462,277.52 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
391,248,041.16 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
32,955,091.35 |
| Total Current Assets |
3,046,564,717.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
121,034,832.37 |
| Investment Properties |
12,767,548.07 |
| Fixed Assetes |
108,470,970.99 |
| Under-construction Projects |
110,188,391.95 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
46,015,623.84 |
| R&D expenses |
-- |
| Goodwill |
26,687,964.88 |
| Long-Term Deferred and Prepaid Expenses |
724,391.12 |
| Deferred Income Tax Assets |
40,256,953.55 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
544,886,475.38 |
| Total Assets |
3,591,451,192.76 |
| Short-Term Loans |
855,852,687.52 |
| Trading Financial liabilities |
70,560,000.00 |
| Notes Payable |
31,000,000.00 |
| Accounts Payable |
416,592,680.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
3,665,122.07 |
| Taxes Payable |
150,598,113.32 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
174,180,068.84 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
49,311,016.83 |
| Other Current Liabilities |
172,469.63 |
| Sub-Total of Current Liabilities |
1,754,437,244.19 |
| Long-term Loans |
211,240,542.22 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
1,065,358.28 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
212,305,900.50 |
| Total Liabilities |
1,966,743,144.69 |
| Paid-In Capital(Or Share Stock) |
139,528,294.00 |
| Capital Surplus |
553,201,344.36 |
| Surplus Reserve |
10,576,537.81 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
922,138,917.13 |
| Minority Stockholder's Interest |
-6,949,105.23 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,631,657,153.30 |
| Owner's Equity（Stockholder's Equity） |
1,624,708,048.07 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,591,451,192.76 |
